VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD
Taking everything into account, VHI scores 7 out of 10 in our fundamental rating. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make VHI a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
VHI had positive earnings in the past year.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 1.16%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a Return On Equity of 1.58%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI's Return On Invested Capital of 3.04% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VHI is in line with the industry average of 3.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 1.58% | ||
| ROIC | 3.04% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI has a Profit Margin of 3.79%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI has a better Operating Margin (11.73%) than 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 80.86%, VHI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.73% | ||
| PM (TTM) | 3.79% | ||
| GM | 80.86% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
The number of shares outstanding for VHI has been increased compared to 5 years ago.
The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
VHI has an Altman-Z score of 6.52. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
VHI has a Altman-Z score of 6.52. This is amongst the best in the industry. VHI outperforms 87.50% of its industry peers.
VHI has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
VHI has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. VHI outperforms 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 6.52 |
ROIC/WACC0.34
WACC8.93%
2.3 Liquidity
A Current Ratio of 2.35 indicates that VHI has no problem at all paying its short term obligations.
The Current ratio of VHI (2.35) is better than 75.00% of its industry peers.
A Quick Ratio of 2.34 indicates that VHI has no problem at all paying its short term obligations.
The Quick ratio of VHI (2.34) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.34 |
3. Growth
3.1 Past
VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.85%.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.97%.
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-53.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)35.97%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%42.07%
3.2 Future
Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 82.32% on average per year.
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.69% yearly.
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 185.17 indicates a quite expensive valuation of VHI.
Based on the Price/Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.57, VHI is valued quite expensively.
VHI is valuated quite expensively with a Price/Forward Earnings ratio of 37.02.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (22.41), we can say VHI is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 185.17 | ||
| Fwd PE | 37.02 |
4.2 Price Multiples
87.50% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.76 | ||
| EV/EBITDA | 33.81 |
4.3 Compensation for Growth
VHI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 82.32% in the coming years.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y107.06%
EPS Next 3Y82.32%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (6/16/2025, 7:00:00 PM)
11.11
+0.11 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners34.31%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap619.72M
Analysts81.67
Price Target14.03 (26.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.15%
Min EPS beat(2)-54.3%
Max EPS beat(2)-33.99%
EPS beat(4)0
Avg EPS beat(4)-61.12%
Min EPS beat(4)-130.46%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.63%
EPS beat(12)1
Avg EPS beat(12)-48.69%
EPS beat(16)2
Avg EPS beat(16)-88.33%
Revenue beat(2)2
Avg Revenue beat(2)2.65%
Min Revenue beat(2)0.61%
Max Revenue beat(2)4.69%
Revenue beat(4)3
Avg Revenue beat(4)2.04%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.69%
Revenue beat(8)6
Avg Revenue beat(8)2.98%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)2.78%
PT rev (1m)-0.45%
PT rev (3m)1.85%
EPS NQ rev (1m)-7.41%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)3.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 185.17 | ||
| Fwd PE | 37.02 | ||
| P/S | 8.26 | ||
| P/FCF | 41.76 | ||
| P/OCF | 39.4 | ||
| P/B | 3.45 | ||
| P/tB | 12.27 | ||
| EV/EBITDA | 33.81 |
EPS(TTM)0.06
EY0.54%
EPS(NY)0.3
Fwd EY2.7%
FCF(TTM)0.27
FCFY2.39%
OCF(TTM)0.28
OCFY2.54%
SpS1.34
BVpS3.22
TBVpS0.91
PEG (NY)0.86
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 1.58% | ||
| ROCE | 4.46% | ||
| ROIC | 3.04% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 11.73% | ||
| PM (TTM) | 3.79% | ||
| GM | 80.86% | ||
| FCFM | 19.78% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 13.02% | ||
| Cap/Sales | 1.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 100.49% | ||
| Profit Quality | 522.09% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.34 | ||
| Altman-Z | 6.52 |
F-Score4
WACC8.93%
ROIC/WACC0.34
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)35.97%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%42.07%
Revenue Next Year30.64%
Revenue Next 2Y19.52%
Revenue Next 3Y26.69%
Revenue Next 5YN/A
EBIT growth 1Y21.18%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year62.54%
EBIT Next 3Y48.37%
EBIT Next 5YN/A
FCF growth 1Y308.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y293.07%
OCF growth 3YN/A
OCF growth 5YN/A